Updated multi-society guidance aligns with broader recommendations which prioritize individualized risk factors for aspiration and other complications, rather than dosing frequency alone
Developments Semaglutide and Liraglutide Litigation On October 6, 2023, Siskinds filed a proposed class action in the Supreme Court of British Columbia on behalf a proposed class of Canadians who suffered injuries arising from the consumption of GLP-1 drugs manufactured by Novo Nordisk, which was subsequently amended on October 3, 2025
This is important because emotional eating often contributes to overeating and weight gain
The glucagon-like peptide 1 receptor agonist exendin-4 induces tenogenesis in human mesenchymal stem cells
Together, the two companies offer a complete, cost-efficient solution to employers seeking to expand coverage for weight management and chronic co-conditions like diabetes, high cholesterol, and hypertension
Medical News Today spoke with five GLP-1 medical experts to find out what exactly is microdosing and how it is different from taking normal amounts of GLP-1 medications, as well as its safety and efficacy